Innovate Biopharmaceuticals Announces Participation at the Jefferies 2018 London Healthcare Conference
October 31, 2018 09:00 ET
|
Innovate Biopharmaceuticals, Inc
RALEIGH, N.C., Oct. 31, 2018 (GLOBE NEWSWIRE) -- Innovate Biopharmaceuticals, Inc. (“Innovate”) (Nasdaq: INNT), a clinical stage biotechnology company focused on developing novel therapeutics for...
Innovate Biopharmaceuticals Announces Positive Effect of Larazotide Acetate on reducing Intestinal Permeability in a NASH Preclinical Study
October 29, 2018 07:00 ET
|
Innovate Biopharmaceuticals, Inc
Top line results showed larazotide having a significant effect on intestinal permeability, a mechanism thought to be key for bacterial translocation leading to NAFLD/NASH Further preclinical data in...
Innovate Biopharmaceuticals Announces Participation at the Ladenburg Thalmann 2018 Healthcare Conference
October 01, 2018 08:30 ET
|
Innovate Biopharmaceuticals, Inc
RALEIGH, N.C., Oct. 01, 2018 (GLOBE NEWSWIRE) -- Innovate Biopharmaceuticals, Inc. (“Innovate”) (Nasdaq: INNT), a clinical stage biotechnology company focused on developing novel therapeutics for...
Innovate Biopharmaceuticals to Host Clinical and Scientific Update Event on Thursday, September 6, 2018, in New York City.
September 06, 2018 07:30 ET
|
Innovate Biopharmaceuticals, Inc
RALEIGH, N.C., Sept. 06, 2018 (GLOBE NEWSWIRE) -- Innovate Biopharmaceuticals, Inc. (Nasdaq: INNT), a clinical stage biotechnology company focused on developing novel therapeutics for autoimmune and...
Innovate Biopharmaceuticals Announces Participation at the 20th Annual Rodman & Renshaw Global Investment Conference in New York City September 4-6, 2018
August 31, 2018 22:00 ET
|
Innovate Biopharmaceuticals, Inc
RALEIGH, N.C., Aug. 31, 2018 (GLOBE NEWSWIRE) -- Innovate Biopharmaceuticals, Inc. (“Innovate”) (Nasdaq: INNT), a clinical stage biotechnology company focused on developing novel therapeutics for...
Innovate Biopharmaceuticals Enters into an Agreement with Amarex Clinical Research for Data Management and Biostatistics for Phase 3 Celiac Disease Trial
August 23, 2018 07:00 ET
|
Innovate Biopharmaceuticals, Inc
RALEIGH, N.C., Aug. 23, 2018 (GLOBE NEWSWIRE) -- Innovate Biopharmaceuticals, Inc. (Nasdaq: INNT), a clinical stage biotechnology company focused on developing novel therapeutics for autoimmune and...
Innovate Biopharmaceuticals Reports Second Quarter 2018 Earnings and Key Corporate Highlights
August 15, 2018 07:10 ET
|
Innovate Biopharmaceuticals, Inc
Added as a member of the broad-market Russell 3000®, 2000® and Microcap® IndexesInnovate plans to host a Clinical and Scientific Update on September 6, 2018, in New York CityMultiple research...
Innovate Biopharmaceuticals to Host Clinical and Scientific Update Event on Thursday, September 6, 2018, in New York City
August 03, 2018 07:05 ET
|
Innovate Biopharmaceuticals, Inc
RALEIGH, N.C., Aug. 03, 2018 (GLOBE NEWSWIRE) -- Innovate Biopharmaceuticals, Inc. (Nasdaq: INNT), a clinical stage biotechnology company focused on developing novel therapeutics for autoimmune and...
Innovate Biopharmaceuticals Enters into a Collaboration on Larazotide’s Effect on Improving the Microbiome of Children with EED with the University of Virginia School of Medicine
July 31, 2018 07:00 ET
|
Innovate Biopharmaceuticals, Inc
RALEIGH, N.C., July 31, 2018 (GLOBE NEWSWIRE) -- Innovate Biopharmaceuticals Inc. (Nasdaq:INNT), a clinical stage biotechnology company focused on developing novel medicines for autoimmune and...
Innovate Biopharmaceuticals Enters into an R&D Collaboration on Larazotide’s Corrective Effect on the Dysfunctional Intestinal Barrier and the Dysfunctional Microbiome in various Diseases with the University of Maryland School of Medicine
June 28, 2018 07:00 ET
|
Innovate Biopharmaceuticals, Inc
RALEIGH, N.C., June 28, 2018 (GLOBE NEWSWIRE) -- Innovate Biopharmaceuticals Inc. (Nasdaq:INNT), a clinical stage biotechnology company focused on developing novel medicines for autoimmune and...